These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31645012)

  • 1. Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E
    Kim M; Sahu A; Hwang Y; Kim GB; Nam GH; Kim IS; Chan Kwon I; Tae G
    Biomaterials; 2020 Jan; 226():119550. PubMed ID: 31645012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory cytokine IL10 loaded cRGD liposomes for the targeted treatment of atherosclerosis.
    Li J; Ding F; Qian X; Sun J; Ge Z; Yang L; Cheng Z
    J Microencapsul; 2021 Sep; 38(6):357-364. PubMed ID: 33048003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deleting interleukin-10 from myeloid cells exacerbates atherosclerosis in Apoe
    Orecchioni M; Wolf D; Suryawanshi V; Winkels H; Kobiyama K; Makings J; Kiosses WB; Ley K
    Cell Mol Life Sci; 2022 Dec; 80(1):10. PubMed ID: 36496494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
    Skiba DS; Nosalski R; Mikolajczyk TP; Siedlinski M; Rios FJ; Montezano AC; Jawien J; Olszanecki R; Korbut R; Czesnikiewicz-Guzik M; Touyz RM; Guzik TJ
    Br J Pharmacol; 2017 Nov; 174(22):4055-4069. PubMed ID: 27935022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis.
    Kim M; Sahu A; Kim GB; Nam GH; Um W; Shin SJ; Jeong YY; Kim IS; Kim K; Kwon IC; Tae G
    J Control Release; 2018 Jan; 269():337-346. PubMed ID: 29175140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LongShengZhi Capsule Reduces Established Atherosclerotic Lesions in apoE-Deficient Mice by Ameliorating Hepatic Lipid Metabolism and Inhibiting Inflammation.
    Ma J; Zhao D; Wang X; Ma C; Feng K; Zhang S; Chen Y; Zhu Y; Gao X; Zhao B; Wang Y; Qian K; Li X; Duan Y; Han J; Yang X
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):105-117. PubMed ID: 30540683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
    Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.
    Almer G; Summers KL; Scheicher B; Kellner J; Stelzer I; Leitinger G; Gries A; Prassl R; Zimmer A; Mangge H
    Int J Nanomedicine; 2014; 9():4211-22. PubMed ID: 25214785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice.
    Xu J; Xia Z; Rong S; Gao H; Yang W; Li J; Ma C; Deng Q; Huang Q; Xiao L; Huang F
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29382111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benzoate plant metabolite ethyl gallate prevents cellular- and vascular-lipid accumulation in experimental models of atherosclerosis.
    Liu W; Liu J; Xing S; Pan X; Wei S; Zhou M; Li Z; Wang L; Bielicki JK
    Biochem Biophys Res Commun; 2021 Jun; 556():65-71. PubMed ID: 33839416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.
    Bhaskar V; Yin J; Mirza AM; Phan D; Vanegas S; Issafras H; Michelson K; Hunter JJ; Kantak SS
    Atherosclerosis; 2011 Jun; 216(2):313-20. PubMed ID: 21411094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice.
    Mulholland M; Jakobsson G; Lei Y; Sundius L; Ljungcrantz I; Rattik S; Tietge UJF; Engelbertsen D
    Atherosclerosis; 2021 Jun; 326():1-10. PubMed ID: 33945906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
    Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of Branched Poly(ß-aminoester) nanoparticles for Interleukin-10 gene delivery in a mouse model of atherosclerosis.
    Distasio N; Dierick F; Ebrahimian T; Tabrizian M; Lehoux S
    Acta Biomater; 2022 Apr; 143():356-371. PubMed ID: 35257950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
    Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
    Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.